化学制品制造

Search documents
金力泰: 关于使用自有闲置资金购买理财产品的公告
Zheng Quan Zhi Xing· 2025-07-01 16:40
Core Viewpoint - The company plans to use up to RMB 500 million of its idle funds to purchase low-risk financial products, aiming to enhance investment returns while ensuring normal business operations are not affected [1][2][4]. Investment Overview - The company intends to invest a maximum of RMB 500 million of its idle funds in low-risk financial products, with the ability to roll over the funds within this limit [2][3]. - The investment will be limited to financial products with a maturity of no more than one year and will not include other securities investments or products linked to stocks or unsecured bonds [2][4]. Risk Control Measures - The company will select reputable financial institutions with strong credit ratings for the investment and will formalize agreements detailing the investment amount, duration, and responsibilities [2][3]. - Internal audits and oversight by independent directors and the supervisory board will be implemented to monitor the use of funds [3][4]. Impact on the Company - The investment in low-risk financial products is expected to enhance the company's investment returns without disrupting normal cash flow or core business operations [3][4]. Approval Process - The proposal was approved in the board and supervisory meetings held on June 30, 2025, and will be submitted for shareholder approval [3][4].
金力泰: 2024年度财务报告非标准审计意见的专项说明
Zheng Quan Zhi Xing· 2025-07-01 16:40
Core Viewpoint - The audit report for Shanghai Jinlitai Chemical Co., Ltd. indicates significant risks related to fund transfers and potential misrepresentation in financial statements, leading to a non-standard audit opinion [2][3][6]. Group 1: Fund Transfer Issues - In 2024, Jinlitai transferred a total of 931 million RMB to related trading companies and received back 930 million RMB, with a remaining balance of 17.87 million RMB at year-end [2]. - There were abnormal fund transfers where related trading companies transferred similar amounts to non-supplier entities, raising concerns about potential fund occupation channels [3]. - The audit could not fully trace the funds to determine the ultimate beneficiaries or the purpose of the funds, indicating a significant risk of non-operational fund occupation [3][6]. Group 2: Equity Transfer Concerns - Jinlitai received a total of 137.53 million RMB as a repayment for equity acquisition from Shihezi Yike, but the funds were subsequently transferred to related trading companies, complicating the audit trail [3][4]. - The second acquisition of equity from Xiamen Yike involved 323 million RMB, with similar issues regarding the tracing of funds and potential misrepresentation of the transaction's commercial substance [5][6]. - The audit report highlights the inability to ascertain the true nature of these transactions and whether they involve non-operational fund occupation [5][6]. Group 3: Audit Opinion and Implications - The audit firm issued a non-opinion report due to the inability to obtain sufficient evidence regarding the financial statements, which could have significant implications for the company's financial health [6][7]. - The overall importance level for the audit was set at 3.66 million RMB based on the company's revenue, indicating the scale of potential misstatements [6]. - The audit firm could not determine the specific financial impact of the identified issues on Jinlitai's financial statements [6][7].
金力泰: 关于调整第八届董事会专门委员会委员的公告
Zheng Quan Zhi Xing· 2025-07-01 16:40
证券代码:300225 证券简称:金力泰 公告编号:2025-051 上海金力泰化工股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 | 主任委员 | | 罗甸 | | --- | --- | --- | | 战略委员会 | 委员 | 唐光泽 | | 委员 | | 汤洋 | | 主任委员 | | 马维华 | | 审计委员会 | 委员 | 于绪刚 | | 委员 | | 唐光泽 | | 主任委员 | | 唐光泽 | | 提名委员会 | 委员 | 于绪刚 | | 委员 | | 罗甸 | | 主任委员 | | 于绪刚 | | 薪酬与考核委员会 | 委员 | 马维华 | | 委员 | | 罗甸 | | 调整后: | | | | 战略委员会 | 主任委员 | 罗甸 | | 委员 | | 唐光泽 | | 委员 | | 吴纯超 | | 主任委员 | | 马维华 | | 审计委员会 | 委员 | 于绪刚 | | 委员 | | 唐光泽 | | 主任委员 | | 唐光泽 | | 提名委员会 | 委员 | 于绪刚 | | 委员 | | 罗甸 | | 主任委员 | | 于绪 ...
闰土股份: 浙江闰土股份有限公司2025年员工持股计划管理办法
Zheng Quan Zhi Xing· 2025-07-01 16:40
Core Viewpoint - Zhejiang Runtou Co., Ltd. has established a 2025 Employee Stock Ownership Plan (ESOP) aimed at enhancing employee engagement and aligning their interests with the company's long-term performance [1][2]. Group 1: Principles of the Employee Stock Ownership Plan - The ESOP is based on principles of legal compliance, voluntary participation, and risk-bearing by participants [2][3]. - Participants in the ESOP are limited to a maximum of 76 employees, including 7 directors and senior management, who are deemed critical to the company's performance [2][3]. Group 2: Funding and Stock Sources - The total amount of self-raised funds for the ESOP is capped at RMB 63 million, with each unit priced at RMB 1 [3][4]. - The stock for the ESOP will be sourced from the company's repurchased shares, with a maximum of 15 million shares available for transfer [4][5]. Group 3: Lock-up and Vesting Periods - The ESOP has a lock-up period of 12, 24, and 36 months, with 40%, 30%, and 30% of shares unlocking at each respective interval [5][6]. - The performance assessment for unlocking shares will be based on the company's net profit growth rates over the specified periods [10][11]. Group 4: Performance Assessment - The performance targets for the ESOP include specific annual net profit growth rates, with a minimum requirement of 20% for the first year and 32% for subsequent years [10][11]. - The assessment will consider both company-level and individual-level performance metrics to determine the unlocking of shares [13][14]. Group 5: Management and Governance - The ESOP will be managed by a committee elected by the participants, ensuring oversight and representation of employee interests [17][20]. - The board of directors retains the authority to modify the ESOP and manage its implementation, subject to shareholder approval [22][23].
金力泰: 2024年年度审计报告
Zheng Quan Zhi Xing· 2025-07-01 16:40
上海金力泰化工股份有限公司 审计报告书 中兴华会计师事务所(特殊普通合伙) ZHONGXINGHUA CERTIFIED PUBLIC ACCOUNTANTS LLP 地址:北京市丰台区丽泽路 20 号丽泽 SOHO B座 20 层 邮编:100073 电话:(010) 51423818 传真:(010) 51423816 目 录 一、审计报告 中兴华会计师事务所(特殊普通合伙) Z H O NG XI N G HU A CE R TIF IE DP U BL IC AC C O U NTA NT SLL P 地 址 ( l o c a t i o n ): 北 京 市 丰 台 区 丽 泽 路 2 0 号 丽 泽 S O H O B 座 2 0 层 电 话 ( t e l ): 0 1 0 - 5 1 4 2 3 8 1 8 传 真 ( f a x ): 0 1 0 - 5 1 4 2 3 8 1 6 审 计 报 告 我们接受委托,审计上海金力泰化工股份有限公司(以下简称"金力泰公司" ) 财务报表,包括 2024 年 12 月 31 日的合并及母公司资产负债表,2024 年度的合 并及母公司利润表、合并及母 ...
金力泰: 关于公司股票交易被实施退市风险警示叠加其他风险警示暨停复牌的公告
Zheng Quan Zhi Xing· 2025-07-01 16:40
证券代码:300225 证券简称:金力泰 公告编号:2025-052 二、公司股票交易被实施其他风险警示的原因 公司聘请的中兴华会计师事务所(特殊普通合伙)对公司 2024 年度内部控 制的有效性进行了审计,并出具了否定意见审计报告。根据《深圳证券交易所创 业板股票上市规则》9.4 第(四)项的规定,最近一个会计年度财务报告内部控 制被出具无法表示意见或者否定意见的审计报告,或者未按照规定披露财务报告 内部控制审计报告的情形,对其股票交易实施其他风险警示(ST)。 上海金力泰化工股份有限公司 关于公司股票交易被实施退市风险警示叠加其他风险警示 暨停复牌的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示: "其他风险 警示",股票简称由"金力泰"变更为"*ST 金泰",证券代码仍为"300225"。 一、公司股票交易被实施退市风险警示的原因 公司聘请的中兴华会计师事务所(特殊普通合伙)对公司 2024 年度财务报 表出具了无法表示意见审计报告。根据《深圳证券交易所创业板股票上市规则》 见或者否定意见的审计报告,对其股票交易实施退市风险警示(*S ...
福莱新材: 福莱新材关于变更注册资本、取消监事会并修订《公司章程》及相关制度的公告
Zheng Quan Zhi Xing· 2025-07-01 16:30
Summary of Key Points Core Viewpoint The announcement details the changes in the registered capital, the cancellation of the supervisory board, and the amendments to the company's articles of association and related systems by Zhejiang Fulai New Materials Co., Ltd. Group 1: Changes in Registered Capital - The company issued 4,290,180 A-share convertible bonds with a total amount of 429.018 million yuan, approved by the China Securities Regulatory Commission [1] - As of May 30, 2025, the total number of shares increased from 201,395,263 to 282,007,606, and the registered capital increased from 201,395,263 yuan to 282,007,606 yuan due to the conversion of bonds into shares [1][2] Group 2: Cancellation of Supervisory Board and Amendments - The company decided to abolish the supervisory board, transferring its powers to the audit committee of the board of directors, in accordance with relevant laws and regulations [2][3] - The company revised its articles of association and related systems to enhance corporate governance and operational norms [2][3] Group 3: Profit Distribution - The company approved a profit distribution plan at the 2024 annual general meeting, distributing a cash dividend of 1.50 yuan per 10 shares and increasing capital by 4 shares for every 10 shares held [1][2] - The total cash dividend distributed amounted to 29,882,735.40 yuan, and 79,687,294 shares were increased as part of the capital reserve [1][2]
福莱新材: 防范控股股东、实际控制人及其他关联方占用资金制度
Zheng Quan Zhi Xing· 2025-07-01 16:30
浙江福莱新材料股份有限公司 第一章 总则 第一条 为进一步健全公司内部控制制度,规范关联交易,建立防止控股股东及其 附属企业、关联方占用浙江福莱新材料股份有限公司(以下简称"公司" )资金的长效机 (以下简称"《公司法》")、 《中华人民共和国证 券法》 (以下简称"《证券法》")、 《上海证券交易所股票上市规则》等法律、法规和规范 性文件,以及《浙江福莱新材料股份有限公司章程》 (以下简称"公司章程" )的有关规 制,杜绝控股股东、实际控制人及其他关联方资金占用行为的发生,根据《中华人民共 和国民典法》 、《中华人民共和国公司法》 第 1 页 共 5 页 第五条 公司董事、高级管理人员应按照《公司章程》、 《董事会议事规则》 、《总经 定,并结合本公司的实际情况,制定本制度。 第二条 本制度所称资金占用包括但不限于以下方式: (一)经营性资金占用,是指控股股东、实际控制人及其他关联方通过采购、销售 等生产经营环节的关联交易产生的资金占用。 (二)非经营性资金占用,是指公司为控股股东、实际控制人及其他关联方垫付的 工资、福利、保险、广告等费用和其他支出,代控股股东、实际控制人及其他关联方偿 还债务而支付资金, ...
福莱新材: 董事、高级管理人员及相关人员持有及买卖本公司股票管理办法
Zheng Quan Zhi Xing· 2025-07-01 16:30
浙江福莱新材料股份有限公司 董事、高级管理人员及相关人员 持有及买卖本公司股票管理办法 第一章 总则 第一条 为进一步加强对浙江福莱新材料股份有限公司(以下简称"公司" 或"本公司")董事、高级管理人员持有及买卖本公司股票的管理,做好相应的 信息披露工作,根据《中华人民共和国公司法》(以下简称"《公司法》")、 《中华人民共和国证券法》(以下简称"《证券法》")、《上市公司董事和高 级管理人员所持本公司股份及其变动管理规则》、《上海证券交易所上市公司自 律监管指引第15号——股东及董事、高级管理人员减持股份》等法律、法规和规 范性文件,以及《浙江福莱新材料股份有限公司章程》(以下简称"公司章程") 的有关规定,并结合本公司的实际情况,制定本办法。 第二条 本办法适用于本公司董事、高级管理人员所持本公司股份及其变动 的管理。 第三条 公司董事和高级管理人员所持本公司股份,是指登记在其名下的所 有本公司股份。公司董事和高级管理人员从事融资融券交易的,还包括记载在其 信用账户内的本公司股份。 第四条 公司董事和高级管理人员在买卖本公司股票及其衍生品种前,应知 悉《公司法》、《证券法》等法律、法规关于内幕交易、操纵市 ...
福莱新材: 董事及高级管理人员薪酬管理制度
Zheng Quan Zhi Xing· 2025-07-01 16:30
Core Points - The company has established a compensation management system for its directors and senior management to enhance motivation and accountability [1][2] - The compensation system is designed to be competitive, reflecting the value of each position, and linked to the company's annual performance [1][3] - The compensation structure includes basic salary and performance bonuses, with the latter tied to annual performance results [2][3] Group 1: Principles of Compensation - The compensation system follows principles of competitiveness, alignment with job value, and integration with company performance [1][2] - It emphasizes a balance between short-term and long-term incentives, ensuring that rewards are linked to performance assessments [1][3] - The system also incorporates a principle of accountability, where compensation is tied to both rewards and penalties [1][2] Group 2: Compensation Structure and Management - The compensation and assessment committee is responsible for determining and reviewing the compensation standards for directors and senior management [2][3] - Directors' compensation is based on their specific roles and contributions, while independent directors receive fixed allowances approved by the shareholders [2][3] - The performance bonuses for senior management are based on annual performance evaluations, with payouts contingent on achieving set targets [3][4] Group 3: Payment and Adjustments - The timing and method of salary payments for directors and senior management are governed by the company's wage distribution policies [3][4] - The company reserves the right to reduce or withhold compensation in cases of misconduct or significant violations of regulations [4][5] - The compensation system is adaptable, allowing for adjustments based on market conditions and the company's operational needs [4][6]